Linked Life Data

18521047

Source:http://linkedlifedata.com/resource/pubmed/id/18521047

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2008-11-10
pubmed:abstractText
Although observational studies showed an apparent lower ischemic coronary disease risk in postmenopausal women receiving hormone therapy (HT), randomized clinical trials in postmenopausal women showed an increase in ischemic cardiovascular events. Soluble cell adhesion molecules have been associated with cardiovascular risk factors and events. HT reduces circulating levels of soluble cell adhesion molecules in healthy postmenopausal women, but its effects in postmenopausal women with coronary artery disease are less clear. We assessed the effect of HT on soluble cell adhesion molecules in the Estrogen Replacement and Atherosclerosis trial.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1530-0374
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1060-4
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:articleTitle
Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
pubmed:affiliation
Department of Internal Medicine/Cardiology and Public Health, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA. jyeboah@wfubmc.edu
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Multicenter Study, Research Support, N.I.H., Extramural